Company intelligence / Profile preview

Biomedical Development

San Antonio, Texas, United Statesbiodevcorp.com ↗

Ownership: Private
Development stage: Other

Overview

BDC’s iodine-based oral rinse demonstrated safety and efficacy against gingivitis in clinical trials, with an unexpected finding of reduced LDL cholesterol levels compared to placebo. Further studies are underway to confirm these results. Other products include a commercial skin care masque and a developing digital health tool for bipolar disorder.

Therapeutic areas: PsychiatryInfectious DiseasesDermatologyOtherCardiovascular
Modalities: DeviceSmall moleculeSoftware platform
Industry: Biotech

Partnerships

NIH SBIR/STTR grantsUniversity of Kentucky Center for Oral Health Research

Beyond the preview

Go deeper on Biomedical Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedical Development.

Explore the full profile